Adam Doyle

902 total citations
20 papers, 444 citations indexed

About

Adam Doyle is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Adam Doyle has authored 20 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 7 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Adam Doyle's work include Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Adam Doyle is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Adam Doyle collaborates with scholars based in Australia, Canada and United Kingdom. Adam Doyle's co-authors include Mark S. Cattral, Anand Ghanekar, Ian D. McGilvray, Markus Selzner, David Grant, Nazia Selzner, Paul D. Greig, Jonathan R. Rumble, Matthew A. Cooper and Mamatha Bhat and has published in prestigious journals such as The Lancet, Journal of Hepatology and Transplantation.

In The Last Decade

Adam Doyle

18 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Doyle Australia 13 229 186 147 81 45 20 444
J. Swain United States 7 120 0.5× 234 1.3× 199 1.4× 22 0.3× 53 1.2× 9 394
Alberto Premoli Italy 10 331 1.4× 150 0.8× 558 3.8× 110 1.4× 134 3.0× 23 679
Carolina Ibarrola Spain 11 159 0.7× 137 0.7× 133 0.9× 9 0.1× 12 0.3× 23 380
Liwei Shi China 12 176 0.8× 210 1.1× 114 0.8× 9 0.1× 8 0.2× 26 359
Keiko Ogita Japan 11 38 0.2× 178 1.0× 51 0.3× 36 0.4× 72 1.6× 34 339
Peter Holland‐Fischer Denmark 12 357 1.6× 155 0.8× 405 2.8× 78 1.0× 122 2.7× 26 656
Maria Grazia Lucà Italy 10 186 0.8× 128 0.7× 160 1.1× 8 0.1× 39 0.9× 23 506
F. Alberino Italy 6 425 1.9× 86 0.5× 415 2.8× 9 0.1× 77 1.7× 8 757
Sophie Chopinet France 9 85 0.4× 118 0.6× 45 0.3× 13 0.2× 15 0.3× 33 303
Grace En Hui Lim Singapore 7 142 0.6× 35 0.2× 296 2.0× 41 0.5× 112 2.5× 9 359

Countries citing papers authored by Adam Doyle

Since Specialization
Citations

This map shows the geographic impact of Adam Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Doyle more than expected).

Fields of papers citing papers by Adam Doyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Doyle. The network helps show where Adam Doyle may publish in the future.

Co-authorship network of co-authors of Adam Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Doyle. A scholar is included among the top collaborators of Adam Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Doyle. Adam Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Weijun, Wendy Cheng, Nick Kontorinis, et al.. (2025). Reduced survival for rural patients with hepatocellular carcinoma within a tertiary hospital network: treatment equality is not enough. Internal Medicine Journal. 55(5). 767–776.
2.
Cheng, Wendy, et al.. (2021). Use of telehealth to increase treatment access for prisoners with chronic hepatitis C. Internal Medicine Journal. 51(8). 1344–1347. 7 indexed citations
3.
Goldaracena, Nicolás, Andre Gorgen, Adam Doyle, et al.. (2019). Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation. Journal of Hepatology. 70(4). 666–673. 69 indexed citations
4.
Aravinthan, Aloysious, Waleed Fateen, Adam Doyle, et al.. (2019). The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation. Transplantation. 103(12). 2523–2530. 26 indexed citations
5.
Hannah, Nicholas, Adam Doyle, Francesco Amico, et al.. (2019). A prospective study of the incidence of drug‐induced liver injury by the modern volatile anaesthetics sevoflurane and desflurane. Alimentary Pharmacology & Therapeutics. 49(7). 940–951. 15 indexed citations
6.
Muaddi, Hala, David Al‐Adra, R. Beecroft, et al.. (2018). Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent. Annals of Surgical Oncology. 25(4). 991–999. 23 indexed citations
7.
Aravinthan, Aloysious, Adam Doyle, Hla‐Hla Thein, et al.. (2017). Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma. Annals of Surgical Oncology. 24(7). 1843–1851. 16 indexed citations
8.
Aravinthan, Aloysious, Andrew S. Barbas, Adam Doyle, et al.. (2017). Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study. Transplant International. 30(11). 1140–1149. 30 indexed citations
9.
Doyle, Adam & Morris Sherman. (2017). Liver Biopsy for Hepatocellular Carcinoma (HCC): Should this be a Routine?. Current Hepatology Reports. 16(1). 46–50. 7 indexed citations
10.
Ng, Siew‐Cheok, Muhammad Janjua, Nickolas Kontorinis, et al.. (2017). Treatment and outcomes of patients with autoimmune overlap syndromes. UWA Profiles and Research Repository (UWA). 32. 100–101. 1 indexed citations
11.
Goldaracena, Nicolás, Adam Doyle, Mark S. Cattral, et al.. (2016). Donor BMI >30 Is Not a Contraindication for Live Liver Donation. American Journal of Transplantation. 17(3). 756–762. 29 indexed citations
12.
Aravinthan, Aloysious, Adam Doyle, Assaf Issachar, et al.. (2016). First-Degree Living-Related Donor Liver Transplantation in Autoimmune Liver Diseases. American Journal of Transplantation. 16(12). 3512–3521. 18 indexed citations
13.
Doyle, Adam, Philip Marsh, Simone I. Strasser, et al.. (2016). Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study. Scandinavian Journal of Gastroenterology. 51(8). 979–985. 9 indexed citations
14.
Doyle, Adam, Rania Rabie, Mark S. Cattral, et al.. (2015). Recipient factors associated with having a potential living donor for liver transplantation. Liver Transplantation. 21(7). 897–903. 12 indexed citations
15.
Doyle, Adam, et al.. (2015). Aceruloplasminaemia: a rare but important cause of iron overload. BMJ Case Reports. 2015. bcr2014207541–bcr2014207541. 19 indexed citations
16.
Doyle, Adam, Geoffrey M Forbes, & Nick Kontorinis. (2011). Autoimmune hepatitis during infliximab therapy for Crohn's disease: A case report. Journal of Crohn s and Colitis. 5(3). 253–255. 28 indexed citations
17.
Corcoran, Tomás, et al.. (2010). Anti-Emetic Dexamethasone and Postoperative Infection Risk: A Retrospective Cohort Study. Anaesthesia and Intensive Care. 38(4). 654–660. 25 indexed citations
18.
Rumble, Jonathan R., Adam Doyle, & Matthew A. Cooper. (1995). Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes. American Journal of Hypertension. 8(1). 53–57. 29 indexed citations
19.
Doyle, Adam. (1986). Hypertension and the heart. Journal of Molecular and Cellular Cardiology. 18. 20–20.
20.
Doyle, Adam. (1961). ESSENTIAL HYPERTENSION AND INHERITANCE OF VASCULAR REACTIVITY. The Lancet. 278(7201). 509–511. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Swain Breakdown of academic impact, for papers by Alberto Premoli Breakdown of academic impact, for papers by Carolina Ibarrola Breakdown of academic impact, for papers by Liwei Shi Breakdown of academic impact, for papers by Keiko Ogita Breakdown of academic impact, for papers by Peter Holland‐Fischer Breakdown of academic impact, for papers by Maria Grazia Lucà Breakdown of academic impact, for papers by F. Alberino Breakdown of academic impact, for papers by Sophie Chopinet Breakdown of academic impact, for papers by Grace En Hui Lim
Rankless by CCL
2026